Record #232655 - GSI Repository

S4DX

The world’s first “digital data-fingerprint” for human blood samples.

Coordinator	SMART4DIAGNOSTICS GMBH
Grant period	2020-04-01 - 2021-09-30
Funding body	European Union
Call number	H2020-EIC-SMEInst-2018-2020-3
Grant number	945530
Identifier	G:(EU-Grant)945530

Note: Smart4Diagnostics (S4DX) has developed the world’s first “digital human sample data-fingerprint” for human blood samples in pre-preanalytics. We aks for EIC-support to catapult this innovation into a market-changing product. S4DX detects and reduces pre-preanalytical errors at sample collection when patients are still present. This is a quantum leap in quality and safety for patients, doctors and laboratories. They receive reliable results and painful re-visits and re-collection of samples are avoided. With our innovation we change medical diagnostics from "trust-based” to “evidence-based”. We provide a complete dataset on the quality of each human sample from blood draw until analysis. Our solution provides the new pre-preanalytical data-standard for sensitive medical diagnostics in the future. S4DX “digital human sample fingerprint” will be the necessary data-baseline for highly sensitive tests (e.g. liquid biopsy). Market-entry in Europe with our MVP is planned for Dec. 2020. Our data will be used to refine our pattern-recognition algorithms and thus provide the basis for personalized and precision diagnostics. We collaborate with leading international partners. Roche Diagnostics and Sarstedt are technical advisors, leading European lab chains (Bioscientia/Germany, Medisupport/Switzerland and Certe/ Netherlands) are implementation partners; Würth Electronics provides access to manufacturers and supply chain partners. The company was founded in Jan. 2018, won the EIT-Health Wildcard as best eHealth start-up in Europe, the Hackathon of the TU Munich/Germany as best start-up and was chosen globally by the WHO as one of ten most promising start-ups in 2018. In April 2019 the Investment committee of the High-Tech-Gründerfonds voted unanimously to accept S4DX for further investment of 1 Mio. €, in July 2019 ACI/ Boston accepted us as one of six companies globally in the “Gold-Track-Program” for massive global scaling in healthcare.

Recent Publications

There are no publications

Record created 2020-09-04, last modified 2023-02-12

Similar records

Add to personal basket
Export as Author List with IDs BibTeX (UTF-8), EndNote XML, EndNote Text, RIS, MARC, Print MARC, MARCXML, DC,
Request correction
Submit fulltext

GSI Homepage \| GSI Library \| English Deutsch \| guest :: login GSI Repository
Search	Submit	Personalize Your alerts Your baskets Your searches	Help